Since the initial characterization of the rodent model in 1974, many laboratories have investigated the pathophysiology of the response to intratracheal bleomycin challenge. In rodents, bleomycin administration results in a route, dose, and strain dependent pulmonary inflammatory response. Given intratracheally, this response is characterized by increases in leukocyte accumulation, fibroblast proliferation, and collagen content. We hypothesized that an unremitting profibrotic inflammatory response is a cause of dysregulated fibrogenesis. Further, we believe that characterization of the cell types and soluble mediators present in the lesion will lend significant insight into the processes modulating pulmonary fibrosis. Recent studies have id...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
RATIONALE: Different sensitivities to profibrotic compounds such as bleomycin are observed among mou...
Since the initial characterization of the rodent model in 1974, many laboratories have investigated ...
Abstract: Previously, macrophage inflammatory protein-1a (MIP-1a), a member of the C-C chemo-kine fa...
Pulmonary fibrosis is the end point of a chronic inflammatory process characterized by leukocyte rec...
Previously, macrophage inflammatory protein‐1α (MIP‐1α), a member of the C‐C chemokine family, has b...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
A progressive fibrosing phenotype is critical in several lung diseases. It is irreversible and assoc...
Pulmonary fibrosis is a common response to a variety of lung injuries, characterized by fibroblast/m...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
RATIONALE: Different sensitivities to profibrotic compounds such as bleomycin are observed among mou...
Since the initial characterization of the rodent model in 1974, many laboratories have investigated ...
Abstract: Previously, macrophage inflammatory protein-1a (MIP-1a), a member of the C-C chemo-kine fa...
Pulmonary fibrosis is the end point of a chronic inflammatory process characterized by leukocyte rec...
Previously, macrophage inflammatory protein‐1α (MIP‐1α), a member of the C‐C chemokine family, has b...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
A progressive fibrosing phenotype is critical in several lung diseases. It is irreversible and assoc...
Pulmonary fibrosis is a common response to a variety of lung injuries, characterized by fibroblast/m...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
RATIONALE: Different sensitivities to profibrotic compounds such as bleomycin are observed among mou...